We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Emerging sources of glycosaminoglycans from fungi highlight their potential as viable alternatives, implying a shift in biopolymer sourcing.
International audience
No takes yet. Share an insight, caveat, or question.
Niego et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: